IP Library › Granted Patent US 11,920,151
Granted Patent B2
US 11,920,151 · App. 16/332,036 · Granted Mar 5, 2024

Method for identifying DNA base editing by means of cytosine deaminase

Inventor: Daesik Kim (Seoul, KR)
Assignees: TOOLGEN INCORPORATED; SEOUL NATIONAL UNIVERSITY R&Db FOUNDATION; INSTITUTE FOR BASIC SCIENCE
C12N15/90C12N9/22C12N9/78C12N15/113C12Q1/6806C12Q1/6869G16B30/00C12Y305/04004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,920,151
App. No.
16/332,036
Granted
Mar 5, 2024
Kind
B2
Abstract

Provided are: a composition for DNA double-strand breaks (DSBs), comprising (1) a cytosine deaminase and an inactivated target-specific endonuclease, (2) a guide RNA, and (3) a uracil-specific excision reagent (USER); a method for producing DNA double-strand breaks by means of a cytosine deaminase using the composition; a method for analyzing a DNA nucleic acid sequence to which base editing has been introduced by means of a cytosine deaminase; and a method for identifying (or measuring or detecting) base editing, base editing efficiency at an on-target site, an off-target site, and/or target specificity by means of a cytosine deaminase.

Claims (23)

1. A method of analyzing nucleic acid sequence of DNA in which a base editing is introduced by cytosine deaminase, comprising:

(i) introducing or contacting (a) a cytosine deaminase and an inactivated target-specific endonuclease, or (b) a cytosine deaminase coding gene and an inactivated target-specific endonuclease coding gene, or (c) a plasmid comprising a cytosine deaminase coding gene and an inactivated target-specific endonuclease coding gene, into a cell or with DNA isolated from a cell, together with a guide RNA;

(ii) treating the DNA with a uracil-specific excision reagent (USER) and generating double strand cleavage in DNA; and

(iii) analyzing nucleic acid sequence of the cleaved DNA fragment,

wherein the DNA isolated from a cell in step (i) is a genomic DNA, and the nucleic acid sequence analysis of step (iii) is performed by whole genome sequencing,

wherein the uracil-specific excision reagent (USER) comprises uracil DNA glycosylase (UDG) and endonuclease VIII, and

wherein the inactivated target-specific endonuclease is a Cas9 protein derived from Streptococcus pyogenes wherein amino acid residue D10 is substituted with alanine.

2. The method of claim 1 , wherein the cytosine deaminase and inactivated target-specific endonuclease are in a form of a fusion protein, or the cytosine deaminase coding gene and inactivated target-specific endonuclease coding gene encode a fusion protein comprising the cytosine deaminase and inactivated target-specific endonuclease.

3. The method of claim 1 , wherein amino acid residue H840 of the inactive target-specific endonuclease is substituted with alanine, and wherein generating double strand cleavage in DNA comprises treating the DNA with an endonuclease specifically cleaving a single strand region of DNA.

4. The method of claim 1 , wherein the guide RNA is a crRNA:tracrRNA duplex in which crRNA and tracrRNA is coupled to each other, or a single-strand guide RNA (sgRNA).

5. The method of claim 1 , which is performed in vitro.

6. A method of identifying a base editing site of cytosine deaminase, comprising:

(i) introducing or contacting (a) a cytosine deaminase and an inactivated target-specific endonuclease, or (b) a cytosine deaminase coding gene and an inactivated target-specific endonuclease coding gene, or (c) a plasmid comprising a cytosine deaminase coding gene and an inactivated target-specific endonuclease coding gene, into a cell or with DNA isolated from a cell, together with a guide RNA;

(ii) treating the DNA with a uracil-specific excision reagent (USER) and generating double strand cleavage in DNA;

(iii) analyzing nucleic acid sequence of the cleaved DNA fragment; and

(iv) identifying the double strand cleavage site in the nucleic acid sequence read obtained by the analysis,

wherein the DNA isolated from a cell in step (i) is a genomic DNA, and the nucleic acid sequence analysis of step (iii) is performed by whole genome sequencing,

wherein the uracil-specific excision reagent (USER) comprises uracil DNA glycosylase (UDG) and endonuclease VIII, and

wherein the inactivated target-specific endonuclease is a Cas9 protein derived from Streptococcus pyogenes wherein amino acid residue D10 is substituted with alanine.

7. The method of claim 6 , wherein the cytosine deaminase and inactivated target-specific endonuclease are in a form of a fusion protein, or the cytosine deaminase coding gene and inactivated target-specific endonuclease coding gene encode a fusion protein comprising the cytosine deaminase and inactivated target-specific endonuclease.

8. The method of claim 6 , wherein amino acid residue H840 of the inactive target-specific endonuclease is substituted with alanine, and wherein generating double strand cleavage in DNA comprises treating the DNA with an endonuclease specifically cleaving a single strand region of DNA.

9. The method of claim 6 , wherein the guide RNA is a crRNA:tracrRNA duplex in which crRNA and tracrRNA is coupled to each other, or a single-strand guide RNA (sgRNA).

10. The method of claim 6 , which is performed in vitro.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2023
From: TOOLGEN INCORPORATED; SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
To: TOOLGEN INCORPORATED; SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION; INSTITUTE FOR BASIC SCIENCE
Reel/Frame 064702/0328 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2019
From: KIM, DAESIK
To: TOOLGEN INCORPORATED; SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
Reel/Frame 048557/0737 →
Continuity (3)
Provisional Application 62445310 · Jan 12, 2017
Provisional Application 62393682 · Sep 13, 2016
Related Publication 20200131536A1 · Apr 30, 2020